The Trump campaign praised a new study that suggests hydroxychloroquine can improve survival odds for some coronavirus patients after the president was criticized for touting the drug.
After repeated failures in previous research, the new study claimed that hospitalized coronavirus patients given hydroxychloroquine early in treatment were 50 percent less likely to die than those who did not receive the drug.
In a statement, Trump's campaign branded the study 'fantastic news', hitting out at critics of the drug who they claimed attempted to discredit it as part of their 'own anti-Trump agenda'.
UK Daily Mail
No comments:
Post a Comment